share_log

HC Wainwright & Co. Maintains Buy on Gritstone Bio, Lowers Price Target to $7

HC Wainwright & Co. Maintains Buy on Gritstone Bio, Lowers Price Target to $7

HC Wainwright & Co.維持對Gritstone Bio的買入,將目標價下調至7美元
Benzinga Real-time News ·  2022/11/07 06:22

HC Wainwright & Co. analyst Sean Lee maintains Gritstone Bio (NASDAQ:GRTS) with a Buy and lowers the price target from $12 to $7.

HC Wainwright & Co. 分析師肖恩·李維持Gritstone Bio(納斯達克股票代碼:GRTS)的買入,並將目標股價從12美元下調至7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論